PDF herunterladen
Thromb Haemost 1973; 29(02): 253-275
DOI: 10.1055/s-0038-1647769
Original Article
Schattauer GmbH

Studies on the Mechanism of Action of Synthetic Antifibrinolytics

A Comparison with the Action of Derivatives of Benzamidine on the Fibrinolytic Process
H Landmann
1   Institute of Pharmacology and Toxicology, Medical Academy of Erfurt, G. D. R
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received for publication 13. Oktober 1972

Publikationsdatum:
30. Juni 2018 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Summary

When compared with derivatives of benzamidine, the synthetic antifibrinolytics EACA, PAMBA, and trans-AMCHA are weak competitive inhibitors of ester hydrolysis by urokinase, of plasminogen activation by urokinase and streptokinase, and of plasmin action on synthetic substrates, casein, and fibrinogen. In contrast, the inhibitory effect of the antifibrinolytics equal or surpass, that of benzamidine derivatives on the process of fibrin dissolution by plasmin and on plasma clot lysis. Degradation of fibrin monomers by plasmin seems to be equally strongly inhibited by the antifibrinolytics. Thus, fibrin and fibrin monomers are plasmin substrates, the hydrolysis of which is inhibited by the antifibrinolytics in a different way from their other inhibitory effects on plasmin. It is concluded that this activity accounts for the strong action of these inhibitors on the whole process of fibrinolysis.

Plasmin, in contrast to other proteolytic enzymes, was shown to possess a specific ability to attack fibrin resulting in rapid formation of soluble products from the insoluble substrate. The strong inhibitory effect of the antifibrinolytics is not caused by their reaction with the substrate, fibrin, but by their blocking the specific interaction of plasmin with fibrin.

The molecular mechanism of the plasmin-fibrin reaction and its inhibition is discussed.

 

  • References

  • 1 Abiko Y, Iwamoto M. 1970; Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by α2-macroglobulin antiplasmin. Biochimica et Biophysica Acta 214: 411.
    CrossrefPubMedGoogle Scholar
  • 2 Ablondi F. B, Hagan J. J, Philips M, de Renzo E. C. 1959; Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by e-aminocaproic acid. Archives of Biochemistry and Biophysics 82: 153.
    CrossrefPubMedGoogle Scholar
  • 3 Alkjaersig N, Fletcher A. P, Sherry S. 1959; e-Aminocaproic acid: An inhibitor of plasminogen activation. The Journal of Biological Chemistry 234: 832.
    PubMedGoogle Scholar
  • 4 Ambrus C. M, Ambrus J. L, Lassman H. B, Mink I. B. 1968; Studies on the mechanism of action of inhibitors of the fibrinolytic system. Annals of the New York Academy of Sciences 146: 430.
    CrossrefPubMedGoogle Scholar
  • 5 Ambrus J. L, Ambrus C. M, Stutzman L, Schimert G, Jacobsen R, Schor J. M, Jainchill J. 1970. Therapeutic studies with fibrinolytic and antifibrinolytic agents. In: Schor J. M. (ed.), Chemical Control of Fibrinolysis-Thrombolysis. Theory and Clinical Applications. Wiley; New York, London, Sidney, Toronto, 153.:
    Google Scholar
  • 6 Baumgarten W, Priester L. I, Stiller D. W, Duncan A. E. W, Ciminera J. L, Loeffler L. J. 1969; 4-Aminomethylbicyclo-(2.2.2)-octane-l-carboxylic acid, a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures. Thrombosis et Diathesis Haemorrhagica 22: 263.
    PubMedGoogle Scholar
  • 7 Bergmeyer H. U. 1970. Methoden der enzymatischen Analyse. Bd. I, 2. Aufl. Akademie-Verlag; Berlin.:
    Google Scholar
  • 8 Blombäck B. 1971; Subunit structure of fibrinogen. Scandinavian Journal of Haematology, Suppl 13: 71.
    PubMedGoogle Scholar
  • 9 Blombäck B, Blombäck M. 1957; Purification of human and bovine fibrinogen. Arkiv for Kemi 10: 415.
    PubMedGoogle Scholar
  • 10 Brockway W. J, Castellino F. J. 1971; The mechanism of inhibition of plasmin activity by epsilon-aminocaproic acid. The Journal of Biological Chemistry 246: 4641.
    PubMedGoogle Scholar
  • 11 Dixon M. 1953; Determination of enzyme inhibitor constants. The Biochemical Journal 55: 170.
    CrossrefPubMedGoogle Scholar
  • 12 Donaldson V. H. 1964; Activation of partially purified plasminogen in the presence of e-amino- caproic acid. The J ournal of Laboratory and Clinical Medicine 63: 213.
    PubMedGoogle Scholar
  • 13 Dubber A. H, McNicol G. P, Douglas A. S. 1965; Amino methyl cyclohexane carbo- xylic acid (AMCHA), a new synthetic fibrinolytic inhibitor. British Journal of Haematology 11: 237.
    CrossrefPubMedGoogle Scholar
  • 14 Egeblad K. 1966; Effects of s-aminocaproic acid on fibrin clot lysis. Thrombosis et Diathesis Haemorrhagica 15: 173.
    PubMedGoogle Scholar
  • 15 Folin O, Ciocalteu V. 1927; Tyrosine and tryptophane determinations in proteins. The Journal of Biological Chemistry 73: 627.
    PubMedGoogle Scholar
  • 16 Fttktjtake K, Shlda K, Arakawa T, Kato K. 1960; Analysis of fibrinolysis by the use of epsilon-aminocaproic acid: Preliminary report. Blood 15: 690.
    PubMedGoogle Scholar
  • 17 Geratz J. D. 1966; p-Aminobenzamidine as inhibitor of trypsinogen activation. Experientia 22: 73.
    CrossrefPubMedGoogle Scholar
  • 18 Geratz J. D. 1967; p-Amidinophenylpyruvic acid: a new effective inhibitor of enterokinase and trypsin. Archives of Biochemistry and Biophysics 118: 91.
    PubMedGoogle Scholar
  • 19 Geratz J. D. 1970; Inhibition of thrombin, plasmin and plasminogen activation by amidino compounds. Thrombosis et Diathesis Haemorrhagica 23: 486.
    PubMedGoogle Scholar
  • 20 Geratz J. D. 1971; Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. Thrombosis et Diathesis Haemorrhagica 25: 391.
    PubMedGoogle Scholar
  • 21 Godal H. C, Theodor I. 1965; In vitro inhibition of streptokinase-induced proteolysis by trasylol and by epsilon amino caproic acid (EACA). The Scandinavian Journal of Clinical and Laboiatory Investigation, 17, Suppl 84: 199.
    PubMedGoogle Scholar
  • 22 Igawa T, Watanabe H, Amano M, Okamoto S. 1959; Viscosimetric study of the action of s - amino - caproic acid on human plasmin. The Keio Journal of Medicine 08: 225.
    CrossrefPubMedGoogle Scholar
  • 23 Iwamoto M, Abiko Y, Shimizu M. 1968; Plasminogen-plasmin system. III. Kinetics of plasminogen activation and inhibition by some synthetic inhibitors. The Journal of Biochemistry 64: 759.
    PubMedGoogle Scholar
  • 24 Kazmirowski H-G, Neuland P, Landmann H, Markwardt F. 1967; Synthese antiproteolytisch wirksamer Derivate der 4 - Aminome thy lb enz o es äur e und anderer Struktur verwandter Verbindungen. Die Pharmazie 22: 465.
    PubMedGoogle Scholar
  • 25 Kowalski E. 1969; Fibrinogenspaltprodukte und ihre Komplexe mit Fibrinmonomeren. Folia Haematologica 92: 20.
    PubMedGoogle Scholar
  • 26 Landmann H. 1967; Vergleichende Untersuchungen über Antifibrinolytika. Folia Haematologica 87: 106.
    PubMedGoogle Scholar
  • 27 Landmann H. 1970; Synthetische Hemmstoffe des Plasmins. Haematologia, Suppl 01: 169.
    PubMedGoogle Scholar
  • 28 Landmann H, Markwardt F. 1970; Irreversible synthetische Inhibitoren der Urokinase. Experientia 26: 145.
    CrossrefPubMedGoogle Scholar
  • 29 Landmann H, Markwardt F, Kazmirowski H-G, Neuland P. 1967; Zusammenhänge zwischen chemischer Konstitution und Antitrypsinwirkung bei Derivaten der 4-Amino- methyl-benzoesäure und anderen strukturverwandten cyclischen Verbindungen. Hoppe- Seyler’s Zeitschrift für Physiologische Chemie 348: 745.
    PubMedGoogle Scholar
  • 30 Loeffler L. J, Britcher S. F, Baumgarten W. 1970; Bridged bicyclic and polycyclic amino acids. Potent new inhibitors of the fibrinolytic process. The Journal of Medicinal Chemistry 13: 926.
    PubMedGoogle Scholar
  • 31 Loewe S. 1953; The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 03: 285.
    PubMedGoogle Scholar
  • 32 Lohmann K, Maekwaedt F, Landmann H. 1963; Über neue Hemmstoffe der Fibrinolyse. Die Naturwissenschaften 50: 502.
    PubMedGoogle Scholar
  • 33 Lohmann K, Maekwardt F, Landmann H. 1964; Zusammenhänge zwischen Konstitution und Wirkung bei Hemmstoffen der Fibrinolyse. Thrombosis et Diathesis Haemorrhagica 10: 424.
    PubMedGoogle Scholar
  • 34 Loeand L, Condit E. V. 1965; Ester hydrolysis by urokinase. Biochemistry 04: 265.
    CrossrefPubMedGoogle Scholar
  • 35 Lukasiewicz H, Niewiarowski S. 1968; In vitro studies on the mechanism of the antifibrinolytic action of e-aminocaproic acid. Thrombosis et Diathesis Haemorrhagica 19: 584.
    PubMedGoogle Scholar
  • 36 Lukasiewicz H, Niewiarowski S, Woeowski K. 1968; The plasmin inhibition by synthetic antifibrinolytic agents in relation to the type of substrate. Biochimica et Biophysica Acta 159: 503.
    CrossrefPubMedGoogle Scholar
  • 37 Maki M, Beller F. K. 1966; Comparative studies of fibrinolytic inhibitors in vitro. Thrombosis et Diathesis Haemorrhagica 16: 668.
    PubMedGoogle Scholar
  • 38 Marder V. J, Shulman N. R. 1969; High molecular weight derivatives of human fibrinogen produced by plasmin. II. Mechanism of their anticoagulant activity. The Journal of Biological Chemistry 244: 2120.
    PubMedGoogle Scholar
  • 39 Mares-Guia M, Shaw E. 1965; Studies on the active center of trypsin. The binding of amidines and guanidines as models of substrate side chain. The Journal of Biological Chemistry 240: 1517.
    PubMedGoogle Scholar
  • 40 Markwardt F, Landmann H. 1967. Antifibrinolytika. Fischer; Jena.:
    Google Scholar
  • 41 Markwardt F, Landmann H, Walsmann P. 1968; Comparative studies on the inhibition of trypsin, plasmin, and thrombin by derivatives of benzylamine and benzamidine. European Journal of Biochemistry 06: 502.
    CrossrefPubMedGoogle Scholar
  • 42 Markwardt F, Neuland P, Klöcking H-P. 1966; Über die antifibrinolytische Wirkung von Estern der 4-Aminomethylbenzoesäure (PAMBA). Die Pharmazie 21: 345.
    PubMedGoogle Scholar
  • 43 Maurer H. R. 1968. Disk-Elektrophorese. Theorie und Praxis der diskontinuierlichen Polyacrylamidgel-Elektrophorese. De Gruyter; Berlin.:
    Google Scholar
  • 44 Maxwell R. E, Allen D. 1966; Interactions of e-amino capr oic acid with the thrombin clotting and fibrinolytic systems. Nature 209: 211.
    CrossrefPubMedGoogle Scholar
  • 45 Maxwell R. E, Lewandowski V, Nickel V. S, Nawrocki J. W. 1967; Substrate modification and the mechanism of potentiation of plasmin inhibition by co-amino acids. Thrombosis et Diathesis Haemorrhagica 18: 299.
    PubMedGoogle Scholar
  • 46 Maxwell R. E, Nawrocki J. W, Nickel V. S. 1968; Some complexities of multiple inhibitor interactions in fibrinolytic systems. Thrombosis et Diathesis Haemorrhagica 19: 117.
    PubMedGoogle Scholar
  • 47 Maxwell R. E, Nawrocki J. W, Nickel V. S. 1970. Multiple inhibitor interactions in the control of fibrinolysis. In: Schor J. M. (ed.), Chemical Control of Fibrinolysis-Thrombolysis. Theory and Clinical Applications; Wiley; New York, London, Sidney, Toronto: 287.
    Google Scholar
  • 48 Melandee B, Gliniecki G, Granstrand B, Hanshoff G. 1964. The aitifibrinolyti- cally active isomer of AMCHA. Xth Congress of the International Society of Haematology. Stockholm 1964, Abstracts G; 68.
    Google Scholar
  • 49 Okamoto S. 1959; Plasmin and antiplasmin. Their pathologic physiology. The Keio Journal of Medicine 08: 211.
    PubMedGoogle Scholar
  • 50 Okamoto S, Nakajima T, Okamoto U, Watanabe H, Iguchi Y, Igawa T, Chien C-C, Hayashi T. 1959; A supressing effect of £-amino-n-caproic acid on the bleeding of dogs, produced with the activation of plasmin in the circulatory blood. The Keio Journal of Medicine 08: 247.
    CrossrefPubMedGoogle Scholar
  • 51 Okamoto S, Sato S, Takada Y, Okamoto U. 1964; An active isomer (trans-form) of AMCHA and its antifibrinolytic (antiplasminic) action in vitro and in vivo. The Keio Journal of Medicine 13: 177.
    CrossrefPubMedGoogle Scholar
  • 52 Ratnoff O. D, Menzie C. 1951; A new method for the determination of fibrinogen in small samples of plasma. The Journal of Laboratory and Clinical Medicine 37: 316.
    PubMedGoogle Scholar
  • 53 Roka L. 1967; Discussion résumé. Thrombosis et Diathesis Haemorrhagica, Suppl 22: 67.
    PubMedGoogle Scholar
  • 54 Schwick H. G. 1967; Biochemie der Fibrinolyse. Thrombosis et Diathesis Haemorrhagica, Suppl 22: 27.
    PubMedGoogle Scholar
  • 55 Sherry S. 1954; The fibrinolytic activity of streptokinase activated human plasmin. The Journal of Clinical Investigation 33: 1054.
    CrossrefPubMedGoogle Scholar
  • 56 Sherry S, Alkjaersig N, Fletcher A. P. 1966; Activity of plasmin and streptokinase activator on substituted arginine and lysine esters. Thrombosis et Diathesis Haemorrhagica 16: 18.
    PubMedGoogle Scholar
  • 57 Summaria L, Hsieh B, Robbins K. C. 1967; Specific mechanism of activation of human plasminogen to plasmin. The Journal of Biological Chemistry 242: 4279.
    PubMedGoogle Scholar
  • 58 Wallen P. 1962; Studies on the purification of human plasminogen. I. The preparation of a partially purified human plasminogen with low spontaneous proteolytic activity. Arkiv for Kemi 19: 451.
    PubMedGoogle Scholar
  • 59 Walton P. L. 1967; The hydrolysis of a-N-acetylglycyl-L-Iysine methyl ester by urokinase. Biochimica et Biophysica Acta 132: 104.
    CrossrefPubMedGoogle Scholar